IFNG gene
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (15)
Papers in which this entity is mentioned.
- A guide to transcriptomic deconvolution in cancer. (2026)
- Extrachromosomal DNA-Driven Oncogene Spatial Heterogeneity and Evolution in Glioblastoma. (2025)
- Tumour-wide RNA splicing aberrations generate actionable public neoantigens. (2025)
- Chromosomal instability as a driver of cancer progression. (2025)
- Osteoclasts in Osteosarcoma: Mechanisms, Interactions, and Therapeutic Prospects. (2023)
- Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors. (2023)
- Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma. (2022)
- Macrophage Polarization States in the Tumor Microenvironment. (2021)
- Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity. (2021)
- B cells and tertiary lymphoid structures promote immunotherapy response. (2020)
- Immuno-genomic landscape of osteosarcoma. (2020)
- Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma. (2020)
- Neoadjuvant checkpoint blockade for cancer immunotherapy. (2020)
- The Immune Landscape of Cancer. (2018)
- Effects of alcohol on the endocrine system. (2013)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| ifng | gene | 26 | 48 |
| ifn-γ | gene | 2 | 2 |
| infγ | gene | — | — |
| interferon gamma | gene | — | — |